CSL (ASX:CSL) partnered with Amazon Web Services to apply artificial intelligence and cloud technologies in advancing its biopharmaceutical research and clinical development, the biotechnology company said in a statement on Tuesday.
The collaboration will enable scientists to connect and analyze data, identify targets sooner, accelerate timelines, and assess external opportunities efficiently, while fostering closer links between laboratory and computational work, the statement said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments